ERDERA — European Rare Disease Research Alliance
Supports Romanian rare disease groups through ERDERA partnerships building stronger diagnostic and care innovation.
ERDERA 2026 is a joint transnational call organized by the European Rare Disease Research Alliance, coordinated by INSERM (France) under a partnership implementation period running from 2024 to 2032. The call addresses two priority topics: resolving the diagnosis of undiagnosed rare genetic diseases, and advancing research on complex multifactorial non-genetic rare diseases. Methodological approac…
Transnational research on undiagnosed rare genetic diseases and complex multifactorial non-genetic rare diseases, using functional validation, multi-omics, AI and machine learning, and systems biology approaches, co-funded by UEFISCDI with EUR 1,000,000 for Romanian consortium partners.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see the timeline
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Write proposalGrant Letter of Intent: How to Write an LOI or Letter of Inquiry
Learn what a grant letter of intent is, when funders ask for LOIs or letters of inquiry, what to include, what to avoid, and how funder rules differ.
DocumentsLetter of Support for Grant Applications: Template and Examples
Learn how to write and request a letter of support for a grant, with template structure, examples, reviewer logic, and common mistakes.
Find grantsGovernment Grants for Startups: What Deeptech Founders Should Know
A practical guide to government grants for startups, including Grants.gov, SBIR/STTR, state programs, eligibility, fit, timelines, and when to apply.
More from UEFISCDI
All grants from this funder →PNCDI IV Program 5.2 — Human Resources (Resurse Umane)
🇷🇴UEFISCDI · Romania
Supports Romanian postdoctoral and early-career teams through PNCDI with mobility-focused innovation opportunities.
PNCDI IV Program 5.7 — Partnership for Innovation (Parteneriat pentru Inovare)
🇷🇴UEFISCDI · Romania
Supports Romanian organisations through PNCDI by connecting enterprises and institutions for innovation partnerships.
M-ERA.NET 3 (Advanced Materials & Batteries)
🇷🇴UEFISCDI · Romania
Supports Romanian and European teams through M-ERA.NET with advanced materials and battery innovation projects.
PCE — Exploratory Research Projects (Proiecte de Cercetare Exploratorie)
🇷🇴UEFISCDI · Romania
Offers Romanian senior researchers support through PNCDI exploratory grants for bold innovation ideas.
ERA4Health PREVENTOO — Obesity Prevention Research
🇷🇴UEFISCDI · Romania
Offers Romania-based teams through ERA4Health PREVENTOO to develop obesity prevention innovation with international scope.
TRANSCAN-4 — Translational Research on Cancer Metabolism
🇷🇴UEFISCDI · Romania
Offers Romanian cancer-metabolism teams access to European collaboration through TRANSCAN 4 to advance innovation toward care.
Similar grants
Browse the directory →
Clinical Research for Common Cancers
🇪🇺European Commission · European Union
Funds €7–10M programmes that bring better cancer diagnosis and treatment trials to patients across four or more European countries.
AI Predictive Biomarkers for Chronic Diseases
🇪🇺European Commission · European Union
Funds trustworthy AI biomarker methods that predict chronic-disease progression and treatment response for personalised care.
Cancer Mission: First-in-Human Trials for Rare Cancers
🇪🇺European Commission · European Union
Funds €7–9M projects taking biomarker-guided rare-cancer treatments into first-in-human, multicentre phase 1 trials.
Towards Artificial General Intelligence (AGI) for healthcare
🇪🇺European Commission · European Union
Funds a European community and roadmap for trustworthy frontier AI models in healthcare.
EIC Pre-Accelerator
🇧🇬EIC · European Union
Funds early-stage European deep-tech firms developing evidence-ready prototypes and proof-of-concept solutions.
Personalised approaches to reduce risks from adverse drug reactions due to multiple medications
🇪🇺European Commission · European Union
Funds safer medication management using biomarkers, clinical data and decision support.